APA

Fay J. W., Wingard J. R., Antin J. H., Collins R. H., Piñeiro L. A., Blazar B. R., Saral R., Bierer B. E., Przepiorka D., Fitzsimmons W. E., Maher R. M. & Weisdorf D. J. (19960517). FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. : Blood.

Chicago

Fay J W, Wingard J R, Antin J H, Collins R H, Piñeiro L A, Blazar B R, Saral R, Bierer B E, Przepiorka D, Fitzsimmons W E, Maher R M and Weisdorf D J. 19960517. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. : Blood.

Harvard

Fay J. W., Wingard J. R., Antin J. H., Collins R. H., Piñeiro L. A., Blazar B. R., Saral R., Bierer B. E., Przepiorka D., Fitzsimmons W. E., Maher R. M. and Weisdorf D. J. (19960517). FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. : Blood.

MLA

Fay J W, Wingard J R, Antin J H, Collins R H, Piñeiro L A, Blazar B R, Saral R, Bierer B E, Przepiorka D, Fitzsimmons W E, Maher R M and Weisdorf D J. FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. : Blood. 19960517.